tocophersolan has been researched along with Nasopharyngeal Carcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Y; Li, X; Li, Z; Mei, L; Xu, G; Yan, M; Zheng, Y; Zhou, Y | 1 |
1 other study(ies) available for tocophersolan and Nasopharyngeal Carcinoma
Article | Year |
---|---|
Nanoformulation of D-α-tocopheryl polyethylene glycol 1000 succinate-b-poly(ε-caprolactone-ran-glycolide) diblock copolymer for siRNA targeting HIF-1α for nasopharyngeal carcinoma therapy.
Topics: Animals; Antineoplastic Agents; Carcinoma; Cell Line, Tumor; Cell Survival; Drug Carriers; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Nanoparticles; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Polyesters; Polyethylene Glycols; RNA, Small Interfering; Vitamin E | 2015 |